These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9543753)

  • 1. [Infection with T-lymphotropic virus in Dutch blood donors, 1993-1996].
    Zaaijer HL; Lelie PN; van der Poel CL
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1571-2. PubMed ID: 9543753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
    Khameneh ZR; Baradaran M; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
    Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
    J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
    Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
    Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors].
    Zaaijer HL; Dudok de Wit C; Cuypers HT; Winkel IN; Lelie PN
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2541-3. PubMed ID: 8272141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
    Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
    Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood safety strategies for human T-cell lymphotropic virus in Europe.
    Laperche S; Worms B; Pillonel J; ;
    Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands.
    Prinsze FJ; Zaaijer HL
    Vox Sang; 2012 Apr; 102(3):198-203. PubMed ID: 21895678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
    Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
    BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-lymphotropic virus type II and neurological disease.
    Araujo A; Hall WW
    Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection].
    Soriano V; Calderón E; Cilla G; Aguilera A; Merino F; Gutiérrez M
    Med Clin (Barc); 1993 Apr; 100(13):492-6. PubMed ID: 8479231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic virus infection: is it a threat?
    Zaaijer H
    Transplant Proc; 1996 Oct; 28(5):2940. PubMed ID: 8908133
    [No Abstract]   [Full Text] [Related]  

  • 19. Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil.
    Namen-Lopes MS; Martins ML; Drummond PC; Lobato RR; ; Carneiro-Proietti AB
    Transfus Med; 2009 Aug; 19(4):180-8. PubMed ID: 19706135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.